Quetelet (body mass) index and effects of dapagliflozin in chronic kidney disease. Chertow GM, Vart P, Jongs N, Langkilde AM, et al. Diabetes Obes Metab 2022;24:827-837.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chertow GM, Vart P, Jongs N, Langkilde AM, et al. Quetelet (body mass) index and effects of dapagliflozin in chronic kidney disease. Diabetes Obes Metab 2022;24:827-837.
PMID: 34984791